title: Reply to John Samuel Banerji's letter to the editor re: Constantijn H.J. Muselaers, Otto C. Boerman, Egbert Oosterwijk, Johannes F. Langenhuijsen, Wim J.G. Oyen, Peter F.A. Mulders. Indium-111-labeled girentuximab immunoSPECT as a diagnostic tool in clear cell renal cell carcinoma. Eur Urol 2013;63:1101-6.
authors.forename: Constantijn H J
authors.initials: CH
authors.lastname: Muselaers
authors.forename: Otto C
authors.initials: OC
authors.lastname: Boerman
authors.forename: Egbert
authors.initials: E
authors.lastname: Oosterwijk
authors.forename: Johan F
authors.initials: JF
authors.lastname: Langenhuijsen
authors.forename: Wim J G
authors.initials: WJ
authors.lastname: Oyen
authors.forename: Peter F A
authors.initials: PF
authors.lastname: Mulders
mesh_terms: D000911:Antibodies, Monoclonal; D000951:Antigens, Neoplasm / Q000276:immunology*; D002256:Carbonic Anhydrases / Q000276:immunology*; D002292:Carcinoma, Renal Cell / Q000000981:diagnostic imaging*; D005260:Female; D006801:Humans; D007205:Indium Radioisotopes; D007680:Kidney Neoplasms / Q000000981:diagnostic imaging*; D008297:Male; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals
chemical_list: D000911:Antibodies, Monoclonal; D000951:Antigens, Neoplasm; D007205:Indium Radioisotopes; D019275:Radiopharmaceuticals; D002256:Carbonic Anhydrases